Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$17.8M Buy
363,029
+37,054
+11% +$1.86M 0.01% 1033
2014
Q2
$18.4M Buy
325,975
+134,302
+70% +$6.86M 0.01% 931
2014
Q1
$10.3M Sell
191,673
-15,997
-8% -$993K 0.01% 1247
2013
Q4
$10.5M Buy
207,670
+13,770
+7% +$599K 0.01% 1217
2013
Q3
$7.4M Buy
193,900
+63,056
+48% +$1.86M 0.01% 1369
2013
Q2
$2.88M Buy
+130,844
New +$2.86M ﹤0.01% 2144

Other funds holding INCY

UBS's INCY Position: Q3 2014 in Review

UBS increased its Incyte (INCY) stake by 11% in Q3 2014, buying an estimated $1.86M and bringing the position to 363,029 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #1033.

UBS first reported a position in INCY in Q2 2013 and has held it in 6 quarters since. The position peaked at $18.4M in Q2 2014. 220 funds tracked by Wall St. Rank hold INCY as of Q3 2014.

  • UBS held 363,029 shares of Incyte worth $17.8M as of Q3 2014.
  • UBS bought 37,054 Incyte shares in Q3 2014, an estimated $1.86M.
  • Incyte made up 0.01% of UBS's portfolio in Q3 2014, its #1033 holding.
  • UBS first reported a position in Incyte in Q2 2013 and has held it in 6 quarters since.
  • UBS's Incyte position peaked at $18.4M in Q2 2014.
  • 220 funds tracked by Wall St. Rank held Incyte as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.